Quotient Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
9,783
+798
+9% +$92.1K 0.03% 112
2025
Q4
$946K Sell
8,985
-452
-5% -$42.4K 0.03% 126
2025
Q3
$792K Buy
9,437
+734
+8% +$60.5K 0.02% 139
2025
Q2
$689K Buy
8,703
+634
+8% +$50.4K 0.02% 151
2025
Q1
$724K Sell
8,069
-1,177
-13% -$110K 0.02% 138
2024
Q4
$920K Sell
9,246
-1,566
-14% -$161K 0.03% 110
2024
Q3
$1.23M Sell
10,812
-2,015
-16% -$239K 0.04% 91
2024
Q2
$1.59M Buy
12,827
+3,338
+35% +$430K 0.06% 74
2024
Q1
$1.25M Buy
9,489
+2,023
+27% +$249K 0.04% 99
2023
Q4
$814K Buy
+7,466
New +$775K 0.03% 137

Other funds holding MRK

Quotient Wealth Partners's MRK Position: Q1 2026 in Review

Quotient Wealth Partners increased its Merck (MRK) stake by 8.9% in Q1 2026, buying an estimated $92.1K and bringing the position to 9,783 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #112.

Quotient Wealth Partners first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.59M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Quotient Wealth Partners held 9,783 shares of Merck worth $1.18M as of Q1 2026.
  • Quotient Wealth Partners bought 798 Merck shares in Q1 2026, an estimated $92.1K.
  • Merck made up 0.03% of Quotient Wealth Partners's portfolio in Q1 2026, its #112 holding.
  • Quotient Wealth Partners first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Quotient Wealth Partners's Merck position peaked at $1.59M in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.